Nicholas Bruchovsky - Publications, H-index & Citations

Nicholas Bruchovsky

University of British Columbia

48H指数

165论文数

9.5K被引数

收录论文 20

发表时间

Mathematically modelling and controlling prostate cancer under intermittent hormone therapy

ASIAN JOURNAL OF ANDROLOGY

IF2.7

2012-01-09

OAAI

Hirata, Yoshito; Tanaka, Gouhei; Bruchovsky, Nicholas; Aihara, Kazuyuki

Mathematical modelling of prostate cancer growth and its application to hormone therapy (vol 368, pg 5029, 2010)

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES

IF3.7

2011-01-28

PREAI

Tanaka, Gouhei; Hirata, Yoshito; Goldenberg, S. Larry; Bruchovsky, Nicholas; Aihara, Kazuyuki

Piecewise affine systems modelling for optimizing hormone therapy of prostate cancer

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES

IF3.7

2010-11-13

PREAI

Suzuki, Taiji; Bruchovsky, Nicholas; Aihara, Kazuyuki

Mathematical modelling of prostate cancer growth and its application to hormone therapy

PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES

IF3.7

2010-11-13

OAAI

Tanaka, Gouhei; Hirata, Yoshito; Goldenberg, S. Larry; Bruchovsky, Nicholas; Aihara, Kazuyuki

Reply to locally advanced prostate cancer: Biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy

CANCER

IF5.1

2007-06-29

OAAI

Bruchovsky, Nicholas; Klotz, Laurence; Crook, Juanita

Locally advanced prostate cancer - Biochemical results from a prospective phase II study of intermittent androgen suppression for men with evidence of prostate-specific antigen recurrence after radiotherapy

CANCER

IF5.1

2007-01-30

OAAI

Bruchovsky, Nicholas; Klotz, Laurence; Crook, Juanita; Goldenberg, S. Larry

Final results of the Canadian prospective phase II trial of intermittent androgen suppression for men in biochemical recurrence after radiotherapy for locally advanced prostate cancer - Clinical parameters

CANCER

IF5.1

2006-07-05

OAAI

Bruchovsky, Nicholas; Klotz, Laurence; Crook, Juanita; Malone, Shawn; Ludgate, Charles; Morris, W. James; Gleave, Martin E.; Goldenberg, S. Larry

Dihydrotestosterone and the prostate:: the scientific rationale for 5α-reductase inhibitors in the treatment of benign prostatic hyperplasia

JOURNAL OF UROLOGY

IF6.8

2004-10-01

232

PREAI

Andriole, G; Bruchovsky, N; Chung, LWK; Matsumoto, AM; Rittmaster, R; Roehrborn, C; Russell, D; Tindall, D

Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells

CLINICAL CANCER RESEARCH

IF10.2

2004-03-10

OAAI

Blaszczyk, N; Masri, BA; Mawji, NR; Ueda, T; McAlinden, G; Duncan, CP; Bruchovsky, N; Schweikert, HU; Schnabel, D; Jones, EC; Sadar, MD

Ligand-independent activation of the androgen receptor by interleukin-6 and the role of steroid receptor coactivator-1 in prostate cancer cells

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2002-10-01

303

OAAI

Ueda, T; Mawji, NR; Bruchovsky, N; Sadar, MD

Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2002-03-01

375

OAAI

Ueda, T; Bruchovsky, N; Sadar, MD

Prostate cancer: molecular biology of early progression to androgen independence

ENDOCRINE-RELATED CANCER

IF4.6

1999-12-01

165

OAAI

Sadar, MD; Hussain, M; Bruchovsky, N

Selective activation of the probasin androgen-responsive region by steroid hormones

JOURNAL OF MOLECULAR ENDOCRINOLOGY

IF3.8

1999-06-01

OAAI

Kasper, S; Rennie, PS; Bruchovsky, N; Lin, L; Cheng, H; Snoek, R; Dahlman-Wright, K; Gustafsson, JÅ; Shiu, RPC; Sheppard, PC; Matusik, RJ

Intermittent androgen suppression for prostate cancer: rationale and clinical experience 前列腺癌的间歇性雄激素抑制: 原理和临床经验

PROSTATE CANCER AND PROSTATIC DISEASES

IF5.8

1999-01-14

OAAI

Gleave, M; Goldenberg, SL; Bruchovsky, N; Rennie, P

Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model

JOURNAL OF CELLULAR BIOCHEMISTRY

IF2.8

1998-06-01

PREAI

Gleave, ME; Sato, N; Sadar, M; Yago, V; Bruchovsky, N; Sullivan, L

Intermittent androgen suppression for prostate cancer: Rationale and clinical experience 前列腺癌的间歇性雄激素抑制: 原理和临床经验

EUROPEAN UROLOGY

IF25.2

1998-01-01

PREAI

Gleave, M; Bruchovsky, N; Goldenberg, SL; Rennie, P

Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-jun in the human prostate cancer cell line LNCaP

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

1997-07-01

199

OAAI

Sato, N; Sadar, MD; Bruchovsky, N; Saatcioglu, F; Rennie, PS; Sato, S; Lange, PH; Gleave, ME

Editorial comment

JOURNAL OF UROLOGY

IF6.8

1997-06-01

PREAI

Goldenberg, SL; Gleave, ME; Bruchovsky, N; Rennie, P

Neoadjuvant androgen withdrawal therapy decreases local recurrence rates following tumor excision in the Shionogi tumor model

JOURNAL OF UROLOGY

IF6.8

1997-05-01

PREAI

Gleave, ME; Sato, N; Goldenberg, SL; Stothers, L; Bruchovsky, N; Sullivan, LD

Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer

JOURNAL OF UROLOGY

IF6.8

1996-01-01

160

PREAI

Gleave, ME; Goldenberg, SL; Jones, EC; Bruchovsky, N; Sullivan, LD

研究方向